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Abstract
The imbalance in the protease-antiprotease system is an integral part of the pathogenesis of acute disorder of cerebrovascular
circulation and diabetes mellitus (DM), but its manifestations in the complication of diabetes by ischemia-reperfusion of the
brain have not been investigated yet. The objective of the work – is to study the dynamics of carotid ischemia-reperfusion
effect on the proteo- and fibrinolytic activity in brain structures of rats with experimental DM.
Rats with the four-month streptozotocin DM were modeled bilateral carotene ischemia during 20 minutes. In homogenates of
brain structures, indicators of proteo- fibrinolytic activity were determined after 1 hour from the beginning of reperfusion and
during the 12th day of the post-ischemic period. In the absence of DM, the proteolytic activity of all or individual indicators is
increased in both periods of the post-ischemic period in the cortex of the frontal and occipital lobes, the fields of hippocampus
CA2 and CA3, and during the 12th day in the field CA1. In rats with diabetes, in all brain structures, there are no changes in
the lysis of azo-albumin and azo-casein in both terms of observation and lysis of collagen progressively decreases.
In rats without DM in the cortex of the studied particles, fields of the hippocampus CA1 and CA2, all or separate indices of
fibrinolytic activity are increased in both periods of the post-ischemic period, in the field CA3 – all indices at the 12th day. In
the presence of diabetes in the cortex of both studied lobes and the field CA1, the fibrinolytic activity decreases in the late
post-ischemic period, in the fields of CA2 and CA3 – during both observation periods.
Conclusion. In the brain structures under investigation at both time intervals, the DM eliminates the reaction of low and high
molecular weight proteins to the ischemia-reperfusion and suppresses fibrinolytic activity.
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Problem statement and analysis of the
recent research
The pathogenesis of ischemic-reperfusion damage of the brain
is polydromic and is realized with the participation of spe-
cific and nonspecific mechanisms. The latter is an imbalance
in the system of protease-antiprotease, which occurs in the
early stages of ischemia and is the part of the mechanisms
of development of excitotoxicity [7] and continues during
later periods, participating in violations of the permeability
of the blood-brain barrier and the occurrence of inflammatory
processes [14].
On the other hand, such an imbalance arises in conditions
of both insulin-deficiency and insulin resistance, that is, it
accompanies the course of type I and type II diabetes mellitus
[8] and occurs due to activation of caspase-3 and ubiquitin-
proteasome system [4].
The growth of pro-sclerotic cytokines’ production in di-
abetes mellitus with and the violation of the relationship be-
tween activators and proteolytic inhibitors increases the fibro-
sis of the extracellular matrix [5, 10, 17], and the resistance
to proteases of glycosylated structural proteins contributes to
the accumulation of modified proteins [11, 12, 16]. Accord-
ing to the literature, the normalization of proteasome activity
may have a protective effect on the development of diabetic
complications [13].
Consequently, both diabetes mellitus and ischemia-reperfusion
of the brain have in their pathogenesis a violation of the pro-
teolytic activity (and, as its separate species – fibrinolytic),
however, in combination of these pathological states proteo-
and fibrinolytic parameters in some brain structures were not
investigated.
The objective of the research was to study the dynamics
of the effect of bilateral carotid ischemia-reperfusion onto
the parameters of proteo- and fibrinolytic activity in the brain
structures of rats with streptozotocin-induced diabetes melli-
tus.
1. Materials and methods
Simulation of DM was performed by single intra-peritoneal
administration of streptozotocin to the two-month non-linear
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laboratory male rats (Sigma, USA, 60 mg/kg of body weight)
[3]. Four months later, groups of rats of identical age without
and with diabetes were formed, which under the calypsol anes-
thesia (70 mg/kg of body weight) were performed bilateral
clipping of the common carotid arteries [1] for 20 minutes
followed by reperfusion lasting for one hour and 12 days.
The level of glycemia was determined by the glucose-oxidase
method. All studies in animals with diabetes were carried out
in their level of glycemia higher than 10 mmol/l.
Animals were withdrawn from the experiment by decapi-
tation under anesthesia (calypsol, 70 mg/kg of body weight).
The brain was taken into the cold and fixed in liquid nitrogen;
the studied structures were identified using the coordinates
of the stereotactic atlas [18]. The parameters of tissue fib-
rinolytic (total (TFA), non-enzymatic (NFA) and enzymatic
(EFA)) and proteolytic (lysis of low-, high-molecular-weight
proteins, and collagen) activity [2] using reagents of Simko
Ltd, Ukraine, were determined in the homogenates of the
cortex of the frontal and occipital lobes (CFL and COL), the
fields of the hippocampus CA1, CA2, and CA3.
Experimental intervention and euthanasia of animals were
performed in compliance with the basic provisions of the
GLP (1981) of the Council of Europe Convention for the
Protection of Vertebrate Animals used for Experimental and
Other Scientific Purposes of March 18, 1986; Directive of the
EEC # 609 of 24.11.1986 and Order of the Ministry of Health
of Ukraine # 690 dated September 23, 2009.
The research results were processed using the applica-
tion package ”Statistica” (”Statsoft”, USA). According to
the Shapiro-Wilk test, the comparison groups had a normal
distribution. The statistical significance of the differences
was estimated by the Student’s t-criterion for the independent
choices. The data is represented in the form of arithmetic
mean and standard deviation.
2. Results of the research and their
discussion
According to the data represented in table 1, in animals with-
out DM in the cortex of both lobes after 20-minute carotid
ischemia with one-hour reperfusion lysis rates of high molec-
ular weight proteins and collagen increased; at the 12th day
of the ischemic-reperfusion period - the lysis of low-, high-
molecular-weight proteins and collagen increased. The dy-
namics in the CFL was in higher indices of lysis of low molec-
ular weight proteins and collagen at the 12th day, and in the
COL - of all of the studied indicators.
In rats with diabetes, in both of the investigated lobes
of the cortex, there were lower lysis rates of low molecular
weight proteins than in animals without this pathology, and in
the COL - also higher azocoll lysis. In the early and late post-
ischemic periods in both lobes of the rats’ cortex, the lysis of
collagen in relation to the indicator in animals with diabetes
without ischemia-reperfusion of the brain was reduced, and
during the 12th day - there was the decrease of this index and
its values in the early terms.
Data on the state of tissue proteolytic activity in the fields
of the hippocampus of rats of various experimental groups are
represented in Table 2.
In the field of the hippocampus CA1 of animals without
diabetes, in relation to the indicators in animals of the control
group, there was the decreased lysis of low molecular weight
proteins in both terms of observation. In addition, at the
12th day in this structure there was also an increased lysis of
high-molecular proteins and collagen. In the fields of CA2
and CA3, in the early post-ischemic period, there was an
increase in the lysis of high-molecular proteins and collagen
relative to these indicators in the control animals; at the 12th
day of the ischemic-reperfusion period, the values of these
indicators remained elevated (in the field of CA2 - at the level
of the previous term, in the field CA3 - increased as for their
values in the early term). Thus, the response of the studied
parameters onto the ischemia-reperfusion in the fields of CA2
and CA3 is similar, but in the field CA1 differs, which is
consistent with existing ideas about the selective sensitivity
of the field CA1 to the ischemia-reperfusion [9].
These parameters were characterized by structural sen-
sitivity to the DM: as to the values in the animals with the
absence of this pathology in the field CA1 of animals with
diabetes the lower lysis index of low molecular weight pro-
teins was detected, and in the fields CA2 and CA3 - the higher
values of lysis of high-molecular proteins and collagen were
determined. It is characteristically, that in animals with DM
in all studied fields of hippocampus and cortex of both lobes
the reaction in both periods of the ischemic-reperfusion pe-
riod consisted of a progressive decrease in lysis of collagen
compared to these indices in diabetes, uncomplicated by cere-
brovascular disruption. Such stability of the reaction allows
us to think of the marker value of this index for the ischemic-
reperfusion injuries of the brain in DM.
The study of the response of fibrinolytic activity indices to
these experimental interventions showed that in the rats with-
out DM after the end of the early and late ischemic-reperfusion
periods in the CFL and the COL, the TFA, NFA and EFA val-
ues were higher than those of the control animals (Table 3).
In addition, during the 12th day of observation, the values of
TFA and EFA significantly exceeded those of the previous
observation period.
In rats with DM there were the higher levels of TFA and
EFA in CFL, and TFA, NFA, and EFA in the COL, than
in animals without this pathology. In the early ischemic-
reperfusion period, no reliable changes in fibrinolytic activity
in the cortex of both lobes were detected, however, at the
12th day of observation, there was a significant decrease of
TFA, NFA and EFA in CFL and TFA and EFA in the COL
both in relation to indices in diabetic rats, uncomplicated by
ischemia-reperfusion of the brain, and in relation to the early
post-ischemic period.
According to the results represented in table 4, in non-
diabetic rats, the reaction to the 20-minute ischemia with
one-hour reperfusion in the field of the hippocampus CA1
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Table 1. Effect of ischemia-reperfusion onto proteolysis indices in the cortex of forehead and nape lobes of male rats in
conditions of diabetes mellitus (M±m, n=11)
Observation group Lysis of low
molecular weight
proteins (µg azo
albumin/g tissue per
hour)
Lysis of high
molecular weight
proteins (µg azo
casein/g tissue per
hour)
Lysis of collagen (µg
azocoll/g tissue per
hour)
Cortex of frontal lobe
Control 129.95±3.82 92.32±2.77 5.76±0.15
Ischemia-reperfusion, 20 min/1 hour 127.69±2.71 111.76±3.21* 6.44±0.15*
Ischemia-reperfusion 12 days 149.50±3.01*ˆ 112.34±1.98* 7.59±0.22*ˆ
Diabetes 105.09±7.31* 97.74±5.02 7.01±0.61
Diabetes and ischemia-reperfusion 20 min/1 hour 105.77±3.09 96.84±4.29 4.41±0.42#
Diabetes and ischemia-reperfusion 12 days 111.45±7.52 102.06±6.31 3.29±0.29#&
Cortex of occipital lobe
Control 124.30±2.47 85.43±2.41 4.98±0.18
Ischemia-reperfusion, 20 min/1 hour 127.69±4.54 115.26±3.37* 6.01±0.26*
Ischemia-reperfusion 12 days 139.86±3.32*ˆ 127.31±4.29*ˆ 6.98±0.21*ˆ
Diabetes 100.46±6.34* 95.71±6.26 6.61±0.56*
Diabetes and ischemia-reperfusion 20 min/1 hour 107.01±5.84 98.20±5.08 5.01±0.29#
Diabetes and ischemia-reperfusion 12 days 98.65±4.98 102.38±5.08 4.15±0.21#&
Notes. In all tables of the article, the reliability of a difference is compared with:
* - control;
ˆ – ischemia-reperfusion (20 min/1 h) in control animals;
# –diabetes;
& - ischemia-reperfusion (20 min/1 h) in animals with diabetes.
was to significant increase in the activity of EFA, in the field
CA2 - in the growth of all the studied parameters, and in the
field CA3 during this period no reliable changes were detected.
During the 12th day of ischemic-reperfusion period, in the
fields CA1 and CA3, the growth of TFA, NFA and EFA; and
in the field CA2 - TFA and EFA both on the control and in
comparison with the values of these indicators in the early
observation period was revealed.
In rats with diabetes there were the higher levels of TFA
and EFA in the field CA1; TFA, NFA and EFA - in the fields
CA2 and CA3 than in animals without it. According to some
authors, violated fibrinolytic activity in diabetes is a risk factor
for stroke, and its normalization is a means of this complica-
tion prevention [6, 13].
After 20-minute ischemia with one-hour reperfusion, in
the rats with DM in the field CA1 there were no reliable
changes in the investigated parameters of tissue fibrinolysis,
in the field CA2 there was a decrease of EFA, in the field CA3
- there was a decrease of TFA and EFA. At the 12th day of
the post-ischemic period in comparison with the indicators in
diabetes without ischemia of the brain in the field CA1 there
was a decrease of TFA and EFA, in the fields CA2 and CA3 -
of TFA, NFA and EFA. In addition, in this period, as for the
early post-ischemic period in the field CA1, there was a lower
activity of the EFA, in the fields CA2 and CA3 - of all of the
studied parameters of fibrinolytic activity.
Consequently, the general tendency in the response of
fibrinolytic activity to the ischemia-reperfusion of the brain in
DM is its inhibition.
3. Conclusions
In the studied brain structures during both time intervals,
the DM eliminates the reaction of low- and high molecu-
lar weight proteins to the ischemia-reperfusion and suppresses
fibrinolytic activity.
4. Prospects for further research in this
direction
The results indicate the expediency of study the contents of
products of oxidative modification of proteins in these struc-
tures of the brain, which will allow us to evaluate the efficacy
of their proteolysis.
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Table 2. Effect of ischemia-reperfusion onto proteolysis indices in different fields of hippocampus of male rats in conditions
of diabetes mellitus (M±m, n=11)
Observation group Lysis of low
molecular weight
proteins (µg azo
albumin/g tissue per
hour)
Lysis of high
molecular weight
proteins (µg azo
casein/g tissue per
hour)
Lysis of collagen (µg
azocoll/g tissue per
hour)
Field of hippocampus CA1
Control 143.51±3.76 107.46±2.87 6.85±0.21
Ischemia-reperfusion, 20 min/1 hour 118.65±5.35* 115.26±4.06 7.43±0.35
Ischemia-reperfusion 12 days 121.05±6.28* 123.13±3.78* 7.84±0.28*
Diabetes 117.52±9.35* 118.65±9.16 8.29±0.76
Diabetes and ischemia-reperfusion 20 min/1 hour 115.26±6.35 107.69±6.82 5.28±0.49#
Diabetes and ischemia-reperfusion 12 days 106.31±6.35 99.35±6.82 4.98±0.49#
Field of hippocampus CA2
Control 144.64±3.79 115.26±2.73 6.45±0.13
Ischemia-reperfusion, 20 min/1 hour 150.29±5.01 143.51±5.08* 8.95±0.41*
Ischemia-reperfusion 12 days 149.31±3.35 148.65±6.55* 10.01±0.57*
Diabetes 129.82±7.24 131.08±6.02* 8.77±0.61*
Diabetes and ischemia-reperfusion 20 min/1 hour 133.34±7.02 124.30±5.71 6.33±0.57#
Diabetes and ischemia-reperfusion 12 days 141.27±7.02 141.30±6.58 5.72±0.41#
Field of hippocampus CA3
Control 137.86±4.76 104.86±2.15 5.49±0.14
Ischemia-reperfusion 20 min/1 hour 127.69±5.43 123.17±3.93* 7.51±0.12*
Ischemia-reperfusion 12 days 131.54±6.09 135.78±4.05*ˆ 8.16±0.12*ˆ
Diabetes 126.56±6.71 123.17±5.91* 8.28±0.72*
Diabetes and ischemia-reperfusion 20 min/1 hour 120.91±5.65 113.25±5.52 5.69±0.52#
Diabetes and ischemia-reperfusion 12 days 118.06±6.29 119.67±7.21 3.02±0.28#&
Table 3. Effect of ischemia-reperfusion onto proteolysis indices in the cortex of frontal and occipital lobes of male rats in
conditions of diabetes mellitus (M±m, n=11)
Observation group Total fibrinolytic
activity (µg
azofibrin/g tissue per
hour)
Non-enzymatic
fibrinolytic activity
(µg azofibrin/g tissue
per hour)
Enzymatic
fibrinolytic activity
(µg azofibrin/g tissue
per hour)
Cortex of frontal lobe
Control 41.58±1.16 21.84±0.49 19.74±0.79
Ischemia-reperfusion, 20 min/1 hour 58.19±1.64* 28.36±1.23* 29.83±1.13*
Ischemia-reperfusion 12 days 63.76±1.08*ˆ 29.67±1.23* 34.09±1.02*ˆ
Diabetes 54.08±3.96* 25.81±2.03 28.27±1.63*
Diabetes and ischemia-reperfusion 20 min/1 hour 54.80±2.08 28.62±1.34 26.18±0.74
Diabetes and ischemia-reperfusion 12 days 39.40±2.16#& 19.64±1.78#& 19.76±0.68#&
Cortex of occipital lobe
Control 34.29±0.60 18.69±0.53 15.60±0.45
Ischemia-reperfusion, 20 min/1 hour 52.14±0.73* 25.69±0.67* 26.44±0.64*
Ischemia-reperfusion 12 days 54.78±0.58*ˆ 25.06±0.34* 29.72±0.48*ˆ
Diabetes 50.68±3.22* 24.12±1.56* 26.55±1.70*
Diabetes and ischemia-reperfusion 20 min/1 hour 47.22±2.79 24.14±1.72 23.07±1.10
Diabetes and ischemia-reperfusion 12 days 42.96±1.94# 24.75±1.36 18.21±1.06#&
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Table 4. Effect of ischemia-reperfusion onto proteolysis indices in different fields of hippocampus of male rats in conditions
of diabetes mellitus (M±m, n=11)
Observation group Total fibrinolytic
activity (µg
azofibrin/g tissue per
hour)
Non-enzymatic
fibrinolytic activity
(µg azofibrin/g tissue
per hour)
Enzymatic
fibrinolytic activity
(µg azofibrin/g tissue
per hour)
Field of hippocampus CA1
Control 50.01±0.92 24.80±0.61 25.21±0.59
Ischemia-reperfusion, 20 min/1 hour 50.85±0.84 23.98±1.09 26.87±0.27*
Ischemia-reperfusion 12 days 56.92±0.77*ˆ 27.74±1.09*ˆ 29.18±0.31*ˆ
Diabetes 62.14±2.97* 27.22±1.89 34.92±2.11*
Diabetes and ischemia-reperfusion 20 min/1 hour 58.42±2.94 28.73±1.44 29.69±1.94
Diabetes and ischemia-reperfusion 12 days 52.87±2.35# 31.69±1.08 21.18±2.04#&
Field of hippocampus CA2
Control 50.74±0.96 24.72±0.81 26.02±0.93
Ischemia-reperfusion, 20 min/1 hour 61.32±1.42* 28.95±1.09* 32.37±0.84*
Ischemia-reperfusion 12 days 58.18±0.82* 24.00±0.89ˆ 34.18±0.63*
Diabetes 72.09±2.94* 34.18±1.38* 37.91±1.84*
Diabetes and ischemia-reperfusion 20 min/1 hour 68.22±4.01 40.29±2.18 27.93±2.69#
Diabetes and ischemia-reperfusion 12 days 46.32±2.02#& 25.24±1.98#& 21.08±1.38#&
Field of hippocampus CA3
Control 50.17±1.44 23.80±0.68 26.37±0.91
Ischemia-reperfusion, 20 min/1 hour 50.89±1.43 24.49±0.36 26.73±1.48
Ischemia-reperfusion 12 days 61.35±1.65*ˆ 28.67±0.41*ˆ 32.68±1.51*ˆ
Diabetes 69.50±3.06* 33.71±2.29* 37.23±2.08*
Diabetes and ischemia-reperfusion 20 min/1 hour 59.49±3.07# 31.06±1.37 31.12±1.52#
Diabetes and ischemia-reperfusion 12 days 48.18±2.16#& 25.02±1.68#& 23.16±1.43#&
